Slideshows Images Quizzes

Yocon

Last reviewed on RxList: 5/12/2008
Drug Description

Yocon ®
(yohimbine hydrochloride, USP)

DESCRIPTION

Yohimbine is a 3alpha -15alpha -20beta -17alpha -hydroxy Yohimbine-16alpha - carboxylic acid methyl ester. The alkaloid is found in Rubaceae and related trees. Also in Rauwolfia Serpentina (L) Benth. Yohimbine is an indolalkylamine alkaloid with chemical similarity to reserpine. It is a crystalline powder, odorless. Each compressed tablet contains (1/12 gr.) 5.4 mg of Yohimbine Hydrochloride.

For Consumers

What are the possible side effects of yohimbine?

If you experience any of the following serious side effects, stop taking yohimbine and seek emergency medical attention:

  • an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
  • a very irregular or fast heartbeat; or
  • confusion or unusual behavior.

Other, less serious side effects are more likely to occur. Continue to take yohimbine and talk to your doctor if you experience

  • dizziness;
  • anxiety, irritability, or nervousness;
  • tremor (shaking);
  • headache; or
  • skin...
Indications & Dosage

INDICATIONS

Yocon (yohimbine hydrochloride) is indicated as a sympathicolytic and mydriatic. It may have activity as an aphrodisiac.

DOSAGE AND ADMINISTRATION

Experimental dosage reported in treatment of erectile impotence:1, 3, 4 1 tablet (5.4 mg) 3 times a day, to adult males taken orally. Occasional side effects reported with this dosage are nausea, dizziness or nervousness. In the event of side effects dosage is to be reduced to ½ tablet 3 times a day, followed by gradual increases to 1 tablet 3 times a day. Reported therapy not more than 10 weeks.3

HOW SUPPLIED

Yocon ® (Yohimbine Hydrochloride, USP) Tablets 1/12 gr 5.4 mg Bottles of 100 - NDC 0516-0001-01 Bottles of 1,000 - NDC 0516-0001-10

 1. A. Morales et al., New England Journal of Medicine: 1221. November 12, 1981.

 3. Weekly Urological Clinical letter, 27:2, July 4, 1983

 4. A. Morales et al., The Journal of Urology 128: 45-47, 1982.

Glenwood, LLC., 111 Cedar Lane, Englewood, NJ 07631. 1-800-542-0772. Page Last Updated: Tuesday, April 1st: 2008. FDA rev date: n/a

Side Effects & Drug Interactions

SIDE EFFECTS

Yohimbine readily penetrates the CNS and produces a complex pattern of responses in lower doses than required to produce peripheral alpha-adrenergic blockade. These include, anti-diuresis, a general picture of central excitation including elevation of blood pressure and heart rate, increased motor activity, irritability, and tremor. Sweating, nausea and vomiting are common after parenteral administration of the drug.1,2 Also dizziness, headache, skin flushing reported when used orally.1,3

DRUG INTERACTIONS

No information provided.

 1. A. Morales et al., New England Journal of Medicine: 1221. November 12, 1981.

 2. Goodman, Gilman - The Pharmacological basis of Therapeutics 6th ed., p. 176- 188, McMillan

 3. Weekly Urological Clinical letter, 27:2, July 4, 1983

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Warnings & Precautions

WARNINGS

Generally, this drug is not proposed for use in females and certainly must not be used during pregnancy. Neither is this drug proposed for use in pediatric, geriatric or cardio-renal patients with gastric or duodenal ulcer history. Nor, should it be used in conjunction with mood-modifying drugs such as antidepressants, or in psychiatric patients in general.

PRECAUTIONS

No information provided.

Overdosage & Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

Renal diseases, and patients sensitive to the drug. In view of the limited and inadequate information at hand, no precise tabulation can be offered of additional contraindications.

Clinical Pharmacology

CLINICAL PHARMACOLOGY

Action

Yocon (yohimbine hydrochloride) blocks presynaptic alpha-2 adrenergic receptors. Its action on peripheral blood vessels resembles that of reserpine, though it is weaker and of shorter duration. Yohimbine's peripheral autonomic nervous system effect is to increase parasympathetic (cholinergic) and decrease sympathetic (adrenergic) activity. It is to be noted that in male sexual performance, erection is linked to cholinergic activity and to alpha-2 adrenergic blockade which may theoretically result in increased penile inflow, decreased penile outflow or both.

Yohimbine exerts a stimulating action on the mood and may increase anxiety. Such actions have not been adequately studied or related to dosage although they appear to require high doses of the drug. Yohimbine has a mild anti-diuretic action, probably via stimulation of hypothalamic centers and release of posterior pituitary hormone.

Reportedly, Yohimbine exerts no significant influence on cardiac stimulation and other effects mediated by beta-adrenergic receptors. Its effect on blood pressure, if any, would be to lower it; however, no adequate studies are at hand to quantitate this effect in terms of Yohimbine dosage.

Medication Guide

PATIENT INFORMATION

No information provided. Please refer to the WARNINGS section.

Health Solutions From Our Sponsors